Healthcare Triangle Inc. (HCTI) shares jumped 34.34% in after-hours trading Wednesday, climbing to $0.40 after the company announced it had completed a significant acquisition. The stock closed the regular session at $0.30, already up 10.24% for the day.

A $50 Million Deal for Spanish Healthcare Tech

According to a Securities and Exchange Commission filing released Wednesday, Healthcare Triangle's subsidiary, Teyame AI Holdings Inc., acquired all outstanding equity interests in two Spanish companies: Teyamé 360 S.L. and Datono Mediación S.L. The seller was Teyame AI LLC, and the transaction officially closed on Thursday.

The total purchase price could reach up to $50 million, structured through a combination of stock and performance-based earnouts.

Breaking Down the Payment Structure

The equity consideration includes $12 million in restricted common stock and $18 million in convertible preferred stock. Share quantities were determined by calculating the average volume-weighted average prices for the five trading days immediately before closing.

There's also an earnout component worth up to $5 million in preferred stock, payable to key management employees of the acquired companies. This earnout is structured in two annual tranches of $2.5 million each, tied to specific gross revenue and earnings before interest, taxes, depreciation, and amortization (EBITDA) targets for fiscal years ending December 31, 2026, and December 31, 2027.

A Troubled Stock Looking for Traction

While the acquisition news sparked enthusiasm, Healthcare Triangle remains in a precarious position. The California-based healthcare information technology company has a market capitalization of just $3.28 million, with a 52-week high of $218.12 and a 52-week low of $0.25.

Over the past 12 months, HCTI stock has plummeted 99.85%. Currently trading at approximately 0.023% of its 52-week range, the stock sits extremely close to its annual low. The company's Relative Strength Index sits at 19.13, indicating oversold conditions.

The significant decline and positioning near the bottom of the 52-week range signal substantial pressure on the stock. For investors, this represents elevated risk, and clear signs of operational recovery will be necessary before market sentiment can meaningfully improve.